Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05769621 · ClinicalTrials.gov registry record
A Retrospective Study to Characterize Participants With Propionic Acidemia
A clinical trial of Propionic Acidemia, sponsored by ModernaTX.
- Recruiting
- Registry status
- 60
- Enrollment target
- 20
- Study locations
NCT05769621 is a study of Propionic Acidemia that is actively recruiting participants, run by ModernaTX. The registered enrollment target is 60 participants, below the 215-participant average among 6 other Propionic Acidemia trials with a reported enrollment target (72% lower). The trial reports 20 study locations across 20 states.
The verdict
NCT05769621, a study of Propionic Acidemia, is actively recruiting participants, sponsored by ModernaTX.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a non-interventional, observational, global, multicenter, study describing participant characteristics, clinical outcomes, and event rates in participants with propionic acidemia (PA).
Conditions Studied
Study Locations (20)
California
- University of Stanford Medical Center - Stanford
Maryland
- Johns Hopkins University - Baltimore
Michigan
- University of Michigan Hospital - Ann Arbor
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Texas
- Texas Children's Hospital - Houston
Washington
- Seattle Children's Hospital - Seattle
Victoria
- Royal Children's Hospital Melbourne - Parkville
Alberta
- Stollery Children's Hospital University of Alberta - Edmonton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-06-16 |
| Est. Completion | 2026-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05769621
The ClinicalTrials.gov registry entry for NCT05769621 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 215-participant average among 6 other Propionic Acidemia trials with a reported enrollment target (72% lower). The listed sponsor is ModernaTX, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Propionic Acidemia appearing as the primary indexed condition, and to 0 interventions.
NCT05769621 reports 20 study locations spanning 20 distinct geographic areas - top geographies include California, Maryland, Michigan.
Frequently Asked Questions
What is clinical trial NCT05769621 about?
NCT05769621 is a clinical study titled "A Retrospective Study to Characterize Participants With Propionic Acidemia". This is a non-interventional, observational, global, multicenter, study describing participant characteristics, clinical outcomes, and event rates in participants with propionic acidemia (PA).
What is the current status of trial NCT05769621?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2023-06-16. Estimated completion is 2026-09-30.
What conditions does trial NCT05769621 study?
This clinical trial studies the following conditions: Propionic Acidemia.
Who is sponsoring clinical trial NCT05769621?
This trial is sponsored by ModernaTX, which has 90 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05769621 being conducted?
This trial has 20 study locations across California, Maryland, Michigan, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Propionic Acidemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia
RECRUITING
-
An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics
RECRUITING
-
A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
RECRUITING · Phase 1
-
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
RECRUITING · Phase 1
-
Anaplerotic Therapy in Propionic Acidemia
COMPLETED · Phase 1
-
"The MaP Study": Mapping the Patient Journey in MMA and PA
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.